Biocartis Group NV announced the restart of its high-throughput ‘ML2’ cartridge manufacturing line. Following a fire that broke out at one of the Company’s warehouse facilities in Mechelen (Belgium) during the night of 30 July 2021, production at the ML2 line was temporarily suspended due to the need for structural repairs to the building and select supporting systems. Those repairs, as well as several subsequent control and quality related procedures, were completed earlier this week. This led to the successful restart of the ML2 line in the night of 21 September 2021.